MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1136/jnis-2022-019527

Медицинская библиотека · Journal of neurointerventional surgery · 2022

Aspirin versus aggressive antiplatelet therapy for acute carotid stenting plus thrombectomy in tandem occlusions: ETIS Registry results.

Marnat Gaultier, Finistis Stefanos, Moreno Ricardo, Sibon Igor, Pop Raoul, Mazighi Mikaël, Clarençon Frédéric, Rosso Charlotte, Dargazanli Cyril, Darcourt Jean, Olivot Jean-Marc, Boulouis Gregoire, Janot Kevin, Moulin Solène, Bourcier Romain, Consoli Arturo, Richard Sébastien, Arquizan Caroline, Vannier Stephane, Richter Sebastian, Gentric Jean-Christophe, Papagiannaki Chrisanthi, Naggara Olivier, Eker Omer F, Lapergue Bertrand, Caroff Jildaz, Gory Benjamin, ETIS Registry Investigators

Наблюдательное исследованиеСтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Patients treated with acute carotid stenting (CAS) may have higher odds of a favorable outcome than those treated without CAS during thrombectomy in tandem occlusions. Antiplatelet therapy is associated with CAS to avoid stent thrombosis, which occurs in around 20% of patients and negatively impacts outcomes. In this study we compared two antiplatelet strategies in tandem occlusion strokes treated with CAS and intracranial thrombectomy in clinical practice.

METHODS

The Endovascular Treatment in Ischemic Stroke Registry is an ongoing prospective observational study involving 21 comprehensive stroke centers performing thrombectomy in France. We analyzed patients with atherosclerotic tandem occlusions treated with acute CAS and intracranial thrombectomy who received at least one antiplatelet agent. Aggressive antiplatelet therapy included oral or intravenous glycoprotein (GP) IIb/IIIa or P2Y12 inhibitors. The primary outcome was cervical carotid artery patency at day 1 imaging follow-up.

RESULTS

Among the 187 included patients, 124 (66.3%) received aspirin alone and 63 (33.7%) received aggressive antiplatelet therapy. There was no significant difference regarding safety outcomes, especially in symptomatic intracerebral hemorrhage, parenchymal hematoma, and procedural complications. There was a significantly higher rate of carotid stent patency at day 1 in the aggressive antiplatelet therapy group (81.7% vs 97.1%, aOR 17.49, 95% CI 1.10 to 277.2, p=0.042). Odds of favorable functional outcome (90-day modified Rankin Scale score 0-2) were similar between the groups (OR 3.04, 95% CI 0.64 to 14.25, p=0.158).

CONCLUSIONS

In tandem occlusions treated with CAS plus thrombectomy, an aggressive antiplatelet regimen was associated with an increased rate of carotid stent patency at day 1 without safety concerns. Randomized trials are warranted to confirm these findings.

Для цитирования: Marnat Gaultier, Finistis Stefanos, Moreno Ricardo, Sibon Igor, Pop Raoul, Mazighi Mikaël, Clarençon Frédéric, Rosso Charlotte, Dargazanli Cyril, Darcourt Jean, Olivot Jean-Marc, Boulouis Gregoire, Janot Kevin, Moulin Solène, Bourcier Romain, Consoli Arturo, Richard Sébastien, Arquizan Caroline, Vannier Stephane, Richter Sebastian, Gentric Jean-Christophe, Papagiannaki Chrisanthi, Naggara Olivier, Eker Omer F, Lapergue Bertrand, Caroff Jildaz, Gory Benjamin, ETIS Registry Investigators. Aspirin versus aggressive antiplatelet therapy for acute carotid stenting plus thrombectomy in tandem occlusions: ETIS Registry results.. Journal of neurointerventional surgery. 2022. DOI: 10.1136/jnis-2022-019527.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.